Tonix Pharmaceuticals Holding Corp.
TNXP
$13.38
$0.141.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.39M | 3.29M | 2.00M | 2.43M | 2.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.39M | 3.29M | 2.00M | 2.43M | 2.58M |
| Cost of Revenue | 1.06M | 1.37M | 3.27M | 943.00K | 1.18M |
| Gross Profit | 4.33M | 1.92M | -1.27M | 1.49M | 1.40M |
| SG&A Expenses | 35.68M | 25.70M | 16.20M | 10.10M | 15.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.68M | 36.36M | 30.29M | 18.48M | 25.06M |
| Operating Income | -48.29M | -33.07M | -28.30M | -16.05M | -22.48M |
| Income Before Tax | -46.91M | -32.01M | -28.27M | -16.83M | -22.11M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.91M | -32.01M | -28.27M | -16.83M | -22.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.91M | -32.01M | -28.27M | -16.83M | -22.11M |
| EBIT | -48.29M | -33.07M | -28.30M | -16.05M | -22.48M |
| EBITDA | -47.80M | -32.61M | -27.81M | -15.56M | -21.98M |
| EPS Basic | -3.98 | -3.59 | -3.86 | -2.84 | -9.77 |
| Normalized Basic EPS | -2.48 | -2.24 | -2.41 | -1.55 | -6.10 |
| EPS Diluted | -3.98 | -3.59 | -3.86 | -2.84 | -9.77 |
| Normalized Diluted EPS | -2.48 | -2.24 | -2.41 | -1.55 | -6.10 |
| Average Basic Shares Outstanding | 11.80M | 8.92M | 7.33M | 5.93M | 2.26M |
| Average Diluted Shares Outstanding | 11.80M | 8.92M | 7.33M | 5.93M | 2.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |